Detalhe da pesquisa
1.
Asah2 Represses the p53-Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis.
J Immunol
; 206(6): 1395-1404, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33547170
2.
Expression profiles and function of IL6 in polymorphonuclear myeloid-derived suppressor cells.
Cancer Immunol Immunother
; 69(11): 2233-2245, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32488308
3.
Lipid Nanoparticle Delivery of Fas Plasmid Restores Fas Expression to Suppress Melanoma Growth In Vivo.
ACS Nano
; 2022 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35939651
4.
Osteopontin Blockade Immunotherapy Increases Cytotoxic T Lymphocyte Lytic Activity and Suppresses Colon Tumor Progression.
Cancers (Basel)
; 13(5)2021 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33670921
5.
Development of mPing-based activation tags for crop insertional mutagenesis.
Plant Direct
; 5(1): e00300, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33506165
6.
Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation.
Cancers (Basel)
; 12(11)2020 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33203146
7.
Autocrine IL6-Mediated Activation of the STAT3-DNMT Axis Silences the TNFα-RIP1 Necroptosis Pathway to Sustain Survival and Accumulation of Myeloid-Derived Suppressor Cells.
Cancer Res
; 80(15): 3145-3156, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32554751
8.
Codon optimized Tol2 transposase results in increased transient expression of a crystallin-GFP transgene in zebrafish.
MicroPubl Biol
; 20202020 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32626847
9.
Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy.
Mol Cancer Res
; 17(2): 420-430, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30429213
10.
Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes.
J Immunother Cancer
; 7(1): 157, 2019 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31228946
11.
H3K4me3 mediates the NF-κB p50 homodimer binding to the pdcd1 promoter to activate PD-1 transcription in T cells.
Oncoimmunology
; 7(9): e1483302, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30228953
12.
An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion.
J Clin Invest
; 128(12): 5549-5560, 2018 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30395540
13.
Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis.
Cell Rep
; 25(11): 3036-3046.e6, 2018 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30540937
14.
SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells.
Cancer Res
; 77(11): 2834-2843, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28381543
15.
The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells.
Oncoimmunology
; 5(12): e1247135, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-28123883
16.
Ceramide mediates FasL-induced caspase 8 activation in colon carcinoma cells to enhance FasL-induced cytotoxicity by tumor-specific cytotoxic T lymphocytes.
Sci Rep
; 6: 30816, 2016 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27487939
17.
CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype.
Oncotarget
; 7(48): 78698-78712, 2016 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27659530